Jeffrey M. Burns
Jeffrey M. Burns
Edward H. Hashinger Professor of Neurology
Verified email at - Homepage
Cited by
Cited by
Brain death worldwide: accepted fact but no global consensus in diagnostic criteria
EFM Wijdicks
Neurology 58 (1), 20-25, 2002
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives
RH Swerdlow, JM Burns, SM Khan
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (8 …, 2014
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis
Y Iturria-Medina, RC Sotero, PJ Toussaint, JM Mateos-Pérez, AC Evans
Nature communications 7 (1), 1-14, 2016
The Alzheimer's disease mitochondrial cascade hypothesis
RH Swerdlow, JM Burns, SM Khan
Journal of Alzheimer's Disease 20 (s2), S265-S279, 2010
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign
JM Burns, RH Swerdlow
Archives of neurology 60 (3), 437-440, 2003
Cardiorespiratory fitness and brain atrophy in early Alzheimer disease
JM Burns, BB Cronk, HS Anderson, JE Donnelly, GP Thomas, A Harsha, ...
Neurology 71 (3), 210-216, 2008
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
RS Turner, RG Thomas, S Craft, CH Van Dyck, J Mintzer, BA Reynolds, ...
Neurology 85 (16), 1383-1391, 2015
Progressive posterior cortical dysfunction: a clinicopathologic series
JA Renner, JM Burns, CE Hou, DW McKeel, M Storandt, JC Morris
Neurology 63 (7), 1175-1180, 2004
Reduced lean mass in early Alzheimer disease and its association with brain atrophy
JM Burns, DK Johnson, A Watts, RH Swerdlow, WM Brooks
Archives of neurology 67 (4), 428-433, 2010
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease
DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative
Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010
Cardiorespiratory fitness and preserved medial temporal lobe volume in Alzheimer's disease
R Honea, GP Thomas, A Harsha, HS Anderson, JE Donnelly, WM Brooks, ...
Alzheimer disease and associated disorders 23 (3), 188, 2009
Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study
RA Honea, E Vidoni, A Harsha, JM Burns
Journal of Alzheimer's disease 18 (3), 553-564, 2009
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, L Minthon, ...
Neurology 85 (14), 1240-1249, 2015
Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease.
J McDowd, L Hoffman, E Rozek, KE Lyons, R Pahwa, J Burns, S Kemper
Neuropsychology 25 (2), 210, 2011
White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease
JM Burns, JA Church, DK Johnson, C Xiong, D Marcus, AF Fotenos, ...
Archives of neurology 62 (12), 1870-1876, 2005
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 1-9, 2015
In vivo staging of regional amyloid deposition
MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ...
Neurology 89 (20), 2031-2038, 2017
The system can't perform the operation now. Try again later.
Articles 1–20